Heidi Klepin
Overview
Explore the profile of Heidi Klepin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LoCastro M, Wang Y, Yu T, Mortaz-Hedjri S, Mendler J, Norton S, et al.
JMIR Form Res
. 2024 Jun;
8:e58503.
PMID: 38935428
Background: Serious illness conversations may help patients avoid unwanted treatments. We previously piloted the telehealth Serious Illness Care Program (SICP) for older adults with acute myeloid leukemia and myelodysplastic syndrome....
2.
Gabbard J, Nur S, Levine B, Lycan Jr T, Pajewski N, Frechman E, et al.
Am J Hosp Palliat Care
. 2023 Dec;
41(11):1280-1287.
PMID: 38133583
: While frailty is a well-established predictor of overall mortality among patients with metastatic non-small cell lung cancer (mNSCLC), its association with patient-reported outcomes is not well-characterized. The goal of...
3.
LoCastro M, Mortaz-Hedjri S, Wang Y, Mendler J, Norton S, Bernacki R, et al.
Blood Adv
. 2023 Dec;
7(24):7597-7607.
PMID: 38088668
Older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) feel shocked and bewildered when diagnosed. Serious illness conversations (SICs) may increase disease understanding and preparations for the future....
4.
DeMari J, Dressler E, Foraker R, Wells B, Smith S, Klepin H, et al.
Gynecol Oncol
. 2023 May;
174:208-212.
PMID: 37224793
Objective: Despite considerable burden of cardiovascular disease (CVD), data on endometrial cancer survivors' CVD perceptions are lacking. We assessed survivors' perspectives on addressing CVD risk during oncology care. Methods: This...
5.
Bhatt V, Ulrich A, Uy G, Stone R, Stock W, Ojelabi M, et al.
JCO Oncol Pract
. 2023 Apr;
19(6):e877-e891.
PMID: 37058684
Purpose: Clinical trials are important for managing older patients with AML. We investigated differences in outcomes of older patients with AML on the basis of whether patients participated in intensive...
6.
Dhakal P, Lyden E, Joshi U, Pyakuryal A, Loh K, Klepin H, et al.
Leuk Lymphoma
. 2023 Jan;
64(3):691-697.
PMID: 36629003
Association between comorbidity burden and patient outcomes has not been adequately investigated in acute promyelocytic leukemia (APL). We utilized the National Cancer Database to evaluate the association of the Charlson-Deyo...
7.
Le-Rademacher J, Mohile S, Unger J, Hudson M, Foster J, Lichtman S, et al.
J Natl Cancer Inst Monogr
. 2022 Dec;
2022(60):135-141.
PMID: 36519818
Although adults aged 65 years or older make up a strong majority of cancer patients, their underrepresentation in cancer clinical trials leads to the lack of representative data to guide...
8.
LoCastro M, Sanapala C, Mendler J, Norton S, Bernacki R, Carroll T, et al.
J Geriatr Oncol
. 2022 Sep;
14(1):101374.
PMID: 36100548
Introduction: Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) have worse survival rates compared to younger patients, and experience more intense inpatient healthcare at the end of...
9.
10.
Loh K, Lin P, Uth J, Quist M, Klepin H, Mustian K
J Geriatr Oncol
. 2018 Apr;
9(4):405-410.
PMID: 29606599
The incidence of cancer in adults aged 60 years and older is expected to rise, and because cancer is associated with aging, the overall prevalence of cancer will rise as...